Efficacy of dienogest (Zafrilla) in the treatment of endometriosis: A literature review using meta-analysis tools
Open Access
- 28 February 2025
- journal article
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (1) , 37-43
Abstract
Background. Various forms of endometrioid disease affect 7–10% of women of reproductive age and are an important factor in reducing fertility and quality of life. The basis of modern comprehensive therapy is surgery and hormonal agents. Aim. To conduct a meta-analysis of the literature on using dienogest (Zafrilla) for treating pain in endometriosis. Materials and methods. The review and meta-analysis were conducted according to the guidelines of the Cochrane Society and in compliance with the recommendations for systematic reviews and meta-analyses. Data sources for the meta-analysis include publications in the PubMed database between 1997 and February 2024 and relevant research articles in Russian mentioning Zafrilla. Keywords such as "dienogest," "endometriosis surgery," "endometriosis treatment," and "endometriosis" were used to identify relevant studies. The main criterion for the primary assessment was pain relief; the additional one was endometrioma and/or pain recurrence, which indicated a disease relapse. For the meta-analysis, studies mentioning Zafrilla were selected. The study protocol is registered online in the International Prospective Registry of Systematic Reviews (CRD3034892022). Results. Based on the analyzed results of previously published studies, it was found that Zafrilla's effectiveness significantly exceeded placebo and (in some studies) was similar to that of the gonadotropin-releasing hormone agonist in reducing the severity and frequency of pain and relapse after surgery for infiltrative endometriosis and endometriomas. The weighted mean difference with the 95% confidence interval was 1.20 in reducing the pain severity and 1.17 in reducing the number of clinical and morphological relapses in endometriomas and infiltrative endometriosis. The magnitude of the effect for spontaneous pregnancy after surgery and/or endometriosis monotherapy with Zafrilla was 0.9 (relative risk with 95% confidence interval). Conclusion. Our study showed that in many medical institutions where Zafrilla was used for endometriosis both alone and with surgery, clinical improvement was achieved in improving clinical manifestations and significantly reducing the disease recurrence rate. The reduction in endometrioma diameters during non-surgical therapy with Zafrilla without surgery in the study by R. Malik et al. shows the possibilities of modern hormonal drugs and narrows the indications for surgery, allowing the preservation of ovarian reserve along with improving patients' quality of life. Dienogest (Zafrilla) was proven to be effective in pain treatment and prevention of pain recurrence after surgical treatment of endometriosis.Keywords
This publication has 12 references indexed in Scilit:
- Dienogest in endometriosis treatment: A narrative literature reviewClinical and Experimental Reproductive Medicine, 2023
- The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-AnalysisReproductive Sciences, 2023
- Pathogenesis and pathogenetic options in endometriosis managementVoprosy Ginekologii, Akušerstva i Perinatologii, 2023
- Effectiveness of medical therapy for preventing ovarian endometriosis recurrence after surgical treatmentVoprosy Ginekologii, Akušerstva i Perinatologii, 2022
- The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatmentGYNECOLOGY, 2021
- Role of Dienogest in Endometriosis in Young WomenThe Journal of Obstetrics and Gynecology of India, 2021
- Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-AnalysisFrontiers in Medicine, 2021
- Targeted therapy for pelvic pain associated with endometriosis. Assessment of quality of life and sexual functionVoprosy Ginekologii, Akušerstva i Perinatologii, 2021
- Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysisJournal of Minimally Invasive Gynecology, 2020
- Visualization of the results of a meta-analysis of clinical studiesRussian Otorhinolaryngology, 2019